Michael G. Kelly
Directeur Technique/Scientifique/R&D chez CureDuchenne
Profil
Michael G.
Kelly is currently the Director at Trinds LLC since 2017 and the Chief Scientific Officer at CureDuchenne since 2011.
Previously, he worked as the President, Chief Executive Officer & Director at MyoTherix, Inc. He was also the Research Director at Amgen, Inc. from 1999 to 2000.
Additionally, he worked as a Director at NeoGenesis Pharmaceuticals, Inc. and as the Senior Vice President-Research & Development at Renovis, Inc. Dr. Kelly holds a doctorate degree from The University of Southampton and an undergraduate degree from the University of Ulster.
Postes actifs de Michael G. Kelly
| Sociétés | Poste | Début |
|---|---|---|
CureDuchenne
 CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | Directeur Technique/Scientifique/R&D | 13/12/2011 |
Trinds LLC
 Trinds LLC Miscellaneous Commercial ServicesCommercial Services Trinds LLC operates as a contract research organization which conducts research in neuromuscular and rare disorders. It offers solutions in clinical operations, data management, patient science liaison services, study measurements, and biostatistics. The company was founded by Avital Cnaan, Heather Gordish-Dressman and Eric Hoffman and is headquartered in Pittsburgh, PA. | Directeur/Membre du Conseil | 01/11/2017 |
Anciens postes connus de Michael G. Kelly
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2000 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Directeur Technique/Scientifique/R&D | - |
NeoGenesis Pharmaceuticals, Inc.
 NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Directeur/Membre du Conseil | - |
MyoTherix, Inc.
 MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Myotherix, Inc. operates as a biopharmaceutical company focuses on the development of therapies. It focuses on the development of innovative therapies for patients suffering from Duchenne muscular dystrophy and other muscle disorders for which there are no treatments. The company was founded by John Kincaid and is headquartered in Emeryville, CA. | Directeur Général | - |
Formation de Michael G. Kelly
| The University of Southampton | Doctorate Degree |
| University of Ulster | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Myotherix, Inc. operates as a biopharmaceutical company focuses on the development of therapies. It focuses on the development of innovative therapies for patients suffering from Duchenne muscular dystrophy and other muscle disorders for which there are no treatments. The company was founded by John Kincaid and is headquartered in Emeryville, CA. | Health Technology |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeoGenesis Pharmaceuticals, Inc. used to discover and develop small molecule drugs. The company was founded in 1997 by Allen H. Michels and was headquartered in Cambridge, MA | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
CureDuchenne
CureDuchenne Financial ConglomeratesFinance CureDuchenne provides funding for research projects and organizations. The company was founded in 2003 by Paul Miller and Debra Miller and is located in Newport Beach, CA. | Finance |
Trinds LLC
Trinds LLC Miscellaneous Commercial ServicesCommercial Services Trinds LLC operates as a contract research organization which conducts research in neuromuscular and rare disorders. It offers solutions in clinical operations, data management, patient science liaison services, study measurements, and biostatistics. The company was founded by Avital Cnaan, Heather Gordish-Dressman and Eric Hoffman and is headquartered in Pittsburgh, PA. | Commercial Services |